News
Press Releases
DermTech Completes Transaction for Asset Sale; Operations Continue Under New Ownership and Management
August 30, 2024
DermTech® in the News
Read how DermTech is changing the world of dermatology.
Healio | 2-GEP test rules out melanoma in real-world study
Dermatology Times | Trust 2 Study Validates DermTech’s 2-GEP 99% Negative Predictive Value
Dermatology Times | Maral Kibarian Skelsey, MD, Shares Insights Into DermTech’s 2-GEP Assay Success
Healio | Gene expression analysis effective in melanoma detection in skin of color
Dermatology Times | DermTech’s 2-GEP Assay Succeeds at Guiding Biopsy Decision-Making for Ambiguous Skin Lesions of All Skin Phototypes
LocalSYR | Wellness Wednesday: innovative test bypasses biopsy to rule out melanoma
Media
Have a press inquiry?